Gilead Sciences Inc. (GILD) Rating Reiterated by Piper Jaffray Cos.


A number of other analysts have also issued reports on GILD. Zacks Investment Research raised shares of Gilead Sciences from a "sell" rating to a "hold" rating in a research note on Wednesday, June 29th.



from Biotech News